Price movement over the last 24 hours
Align Technology, Inc. vs Progressive Corp — how do they compare? Align Technology, Inc. trades at $179.45 (market cap $12.86B), while Progressive Corp trades at $231.86 (market cap $134.33B). The key difference: Progressive Corp is far larger — about 10.4× Align Technology, Inc.'s market cap, and Progressive Corp pays a 6.02% dividend while Align Technology, Inc. pays none. Which is the better fit depends on your goals.
| ALGN | PGR | |
|---|---|---|
Market Cap | $12.86B | $134.33B |
Sector | Health | Financials |
52-Week High | $207.19 | $252.68 |
52-Week Low | $124.88 | $190.40 |
Enterprise Value | $11.92B | $142.55B |
Dividend Yield | — | 6.02% |
Signals from Pluang's Aura AI — not financial advice
Align Technology (ALGN) trades at $179.45, up 0.72% with a bullish technical outlook from moving averages. The company maintains solid profitability with a 10.5% net margin and has beaten EPS estimates for three consecutive quarters. Recent developments include a new manufacturing facility in India and upcoming Q2 2026 earnings on July 29, 2026.
ALGN offers growth potential with a consensus price target of $218.40, representing 22% upside, supported by 73% analyst buy ratings. Risks include European regulatory scrutiny and North American demand pressures. The stock's valuation at 30x P/E requires sustained earnings growth to justify further gains.
Progressive (PGR) trades at $230.72, up 0.52% on the day, with a bullish technical outlook indicated by moving averages and strong support at $228. The stock shows robust fundamentals with revenue growing from $49.6B in 2022 to $87.6B in 2025 and net income surging to $11.3B. Recent earnings beats and a 36% jump in May 2026 net income highlight operational strength. The company maintains a solid net income margin of 12.93% and an impressive ROE of 37.9%.
The outlook for PGR is positive, supported by consistent earnings outperformance and analyst consensus pointing to upside with a $239.75 price target. Key risks include competitive pressures in the insurance sector and potential macroeconomic headwinds affecting consumer spending. Institutional sentiment is mixed but leans bullish, with 39% of analysts rating it a buy. The stock presents a compelling opportunity for growth investors seeking exposure to a financially healthy insurer.
Trailing returns across standard periods
Align is the leading manufacturer of clear dental aligners globally, having pioneered the technology with the introduction of its Invisalign branded aligners in 1998. Since then, Invisalign has become a household name, having treated over 10 million patients with malocclusion (misaligned teeth) through orthodontist and dentist-guided treatment plans. The company maintains dominant market share of clear aligners, despite the introduction of direct-to-consumer competitors upon the expiration of key patents that began in 2017. Align also manufactures intraoral scanners (iTero), used for orthodontic treatment and restorative dental procedures (digital models for crowns, veneers, and implants).
Read more on ALGN →Progressive underwrites private and commercial auto insurance and specialty lines
Read more on PGR →